Key takeaway: Health X Platform Limited's investor presentation highlighted several key financial metrics and strategic insights. The company reported a quarter-on-quarter revenue growth of 16% and a year-on-year growth of 47%. Gross margins improved, with a current quarter margin of 7.9%, up from 6.6% year-on-year. Operating expenses as a percentage of revenue decreased, indicating improved operational efficiency. The presentation emphasized a disciplined approach to capital allocation, drawing on philosophies from notable investors like Warren Buffett and Jeff Bezos. Health X aims to build a scalable healthcare model that serves both urban and rural markets, with over 77% of its business coming from Tier 2 and Tier 3 regions. The company also noted its asset-light model, which keeps depreciation and finance costs low, contributing to overall profitability.

Key takeaway: Health X Platform Limited (formerly Sastasundar Ventures Limited) held its Q4 FY26 earnings call on June 12, 2026, where management discussed the company's transition to a broader healthcare ecosystem. Managing Director and CEO Banwari Lal Mittal highlighted the successful launch of the JITO initiative, aimed at providing affordable healthcare through certified genetic medicines. CFO Lokesh Agarwal reported a 22% year-on-year revenue growth for Q4, reaching Rs 356 crores, and an 18% increase for the full year, totaling Rs 1,283 crores. The company improved its gross margins and reduced EBITDA losses. Management emphasized a focus on technology and operational efficiency, with plans to expand the Retailer Shakti and SastaSundar platforms. They also discussed a corporate restructuring involving the demerger of the finance division into Microsec Resources Ltd. Overall, the call reflected a commitment to growth and innovation in the healthcare sector.

Key takeaway: Health X Platform Limited, formerly known as Sastasundar Ventures Limited, submitted an investor presentation to the BSE and NSE, detailing its operations and financial performance. The presentation highlighted the company's AI-powered digital health platform, emphasizing its commitment to making healthcare accessible and affordable. Key financial metrics for Q4 FY26 included a revenue from operations of ₹378.1 crores, a 34.1% increase year-over-year, and a gross profit of ₹27.5 crores, reflecting a 65.9% increase. The company reported a negative EBITDA of ₹(20.8) crores. The presentation also discussed the company's capital efficiency, working capital management, and expansion plans, including new fulfillment centers in Udaipur and Lucknow. Management noted a significant reduction in working capital days and highlighted the growing total addressable market in the healthcare sector.

Key takeaway: Management reported that SastaSundar Ventures Limited experienced a revenue increase of 22% year-on-year and an 11% quarter-on-quarter growth for Q3 FY26, attributed to improved operational traction in both B2B and B2C segments. Gross margin improved from 6.1% to 7.6% year-on-year. The company emphasized its commitment to combining medical science and technology to enhance healthcare accessibility. Management highlighted the progress of its Retailer Shakti and SastaSundar B2C platforms, with Retailer Shakti on track for EBITDA break-even by Q4 FY26. The company plans to invest in technology and expand product categories, including the launch of its JITO brand. Management also discussed the merger with HealthBuddy and the demerger of its NBFC, Microsec Resources, aiming for a more focused operational structure. The earnings call concluded with management encouraging stakeholders to review the detailed presentation shared on the stock exchange.

Key takeaway: The investor presentation from Sastasundar Ventures Limited, dated February 6, 2026, outlines the company's operations under the proposed name change to Health X Platform Limited. The presentation emphasizes the company's digital platform for pharmacy, wellness, and diagnostics, aiming to provide accessible and affordable healthcare solutions. Management reported strategic priorities for the next five years, including revenue growth, gross margin expansion, and optimizing operating costs. The presentation highlighted a growth track record with a CAGR of 68% from FY15 to FY21 and a 30%+ CAGR goal for future growth. Additionally, the company detailed its capital efficiency and working capital management, showcasing a reduction in working capital days. The document also provided insights into the company's leadership team and financial performance, including revenue from operations and profit metrics for Q3 FY26, indicating a year-on-year revenue increase of 22%.

Key takeaway: The investor presentation from Sastasundar Ventures Limited, dated February 6, 2026, outlines the company's operations under the proposed name change to Health X Platform Limited. The presentation emphasizes the company's digital platform for pharmacy, wellness, and diagnostics, aiming to provide accessible and affordable healthcare solutions. Management reported strategic priorities for the next five years, including revenue growth, gross margin expansion, and optimizing operating costs. The presentation highlighted a growth track record with a CAGR of 68% from FY15 to FY21 and a 30%+ CAGR goal for future growth. Additionally, the company detailed its capital efficiency and working capital management, showcasing a reduction in working capital days. The document also provided insights into the company's leadership team and financial performance, including revenue from operations and profit metrics for Q3 FY26, indicating a year-on-year revenue increase of 22%.